AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Immune

    Glutathione (600mg)

    SubcutaneouslyOnce daily600mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    🇺🇸 GRAS

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Research-only — no FDA/EMA approval
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Free Access

    How It Works

    Glutathione (GSH) is the most abundant intracellular antioxidant, present in virtually every cell at concentrations of 1–10 mM. As a tripeptide of glutamate, cysteine, and glycine, it functions as the primary thiol-redox buffer, neutralizing reactive oxygen species (ROS), supporting Phase II detoxification pathways, and facilitating the excretion of xenobiotics and heavy metals. The reduced form (GSH) donates an electron to neutralize free radicals and is then recycled from its oxidized form (GSSG) via glutathione reductase.

    Quick Start

    • Reconstitution: Add 4.0 mL bacteriostatic water → 150 mg/mL concentration.
    • Typical daily range: 100–200 mg subcutaneously (gradual titration).
    • Storage: Lyophilized: −20 °C; post-reconstitution, refrigerate 2–8 °C; avoid freeze-thaw.
    Detailed Protocol Data

    Typical / Gradual Approach (4 mL = 150 mg/mL)

    Educational only
    Vial Size— affects syringe units
    BAC Water4 mL
    Concentration150.00 mg/mL

    Route: Subcutaneously | Frequency: Once daily

    WeekDoseUnits (per injection)
    Weeks 1–2
    100 mg
    66.7 Units (0.67 mL)
    Weeks 3–4
    150 mg
    100 Units (1.00 mL)
    Weeks 5–8
    200 mg
    2 × 66.7 Units (0.67 mL)

    Studies report administration once daily subcutaneously, or every other day depending on goals. Some protocols use 200 mg 1–2× weekly for maintenance.

    Related compounds

    Reconstitution Steps

    1. Draw 4.0 mL of bacteriostatic water.
    2. Inject slowly down the side; avoid foaming.
    3. Gently swirl/roll until dissolved (do not shake).
    4. Label and refrigerate at 2–8 °C.

    Protocol Overview

    • Goal: Support antioxidant defense, cellular detoxification, and immune function.
    • Schedule: Daily or every-other-day subcutaneous injections for 4–8 weeks.
    • Storage: Lyophilized frozen; reconstituted refrigerated; avoid freeze-thaw.

    Dosing Protocol

    • Initiation: 100 mg daily; increase by ~50 mg every 1–2 weeks.
    • Target: 150–200 mg daily by Wk 3–8.
    • Frequency: Once daily or every other day for maintenance.
    • Cycle Duration: 4–8 weeks; optional 2–4 week washout between.
    • Break between cycles: After an intensive cycle (4–8 weeks), a 2–4 week washout period or transition to a maintenance dose (200 mg × 1–2/wk) is recommended.

    Washout & Cycle Restart

    When can I restart?

    After an intensive cycle (4–8 weeks), a 2–4 week washout period or transition to a maintenance dose (200 mg × 1–2/wk) is recommended.

    Minimum wait period: 2 weeks

    Storage Instructions

    • Lyophilized: Store at −20 °C in dry, dark conditions.
    • Reconstituted: Refrigerate 2–8 °C; use within 2–3 weeks; avoid freeze-thaw.
    • Glutathione is relatively unstable post-reconstitution—use promptly.

    Important Notes

    • 100 Unit/Injection Limit: At 150 mg/mL the 200 mg dose (1.33 mL) is split into 2 × 100 mg at separate sites.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Supports reduction in oxidative stress markers and maintains cellular redox balance.
    • May enhance liver function and support hepatic detoxification pathways.
    • Research suggests immunomodulatory effects, including support for natural killer (NK) cells and T-cells.
    • Clinical studies in skin health show potential effects on melanin index and skin brightness.
    • Generally well-tolerated; rare reports of gastrointestinal discomfort at high doses.

    Potential Side Effects:

    • Injection site reactions (redness, swelling).
    • Abdominal discomfort or cramping.
    • Headache (transient).
    • Rare allergic reaction (rash, hives).
    • Zinc depletion with long-term use.

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    ⚠️ Other
    🟡 Moderate / Theoretical

    Potential renal burden with IV use

    Chronic IV glutathione at high doses may theoretically form renal oxalates. The FDA has not approved injectable glutathione.

    📄 J Cosmet Dermatol 2019

    References

    1. Antioxidant Glutathione: Protective Roles and Regeneration Mechanisms — Antioxidant glutathione: protective roles and regeneration mechanisms
      View Source
    2. Glutathione and Dependent Enzymes: Coordinated Defense Against Oxidative Stress — Glutathione and dependent enzymes: coordinated defense against oxidative stress
      View Source
    3. Glutathione: Roles in Immune Function, Detoxification and Clinical Applications (PMC) — Glutathione: roles in immune function, detoxification, and clinical applications
      View Source
    4. Glutathione Efficacy in NAFLD Treatment: Open-Label Pilot Study (PMC) — Glutathione efficacy in NAFLD treatment: open-label pilot study
      View Source
    5. Glutathione Anti-Aging and Anti-Melanogenic Effects: RCT (PMC) — Glutathione anti-aging and anti-melanogenic effects: RCT
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    0
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇺🇸
    FDA
    GRAS

    Dietary supplement (GRAS)

    Dietary supplement (GRAS)

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    1 Approvals
    0 PubMed
    0 Clinical Studies

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu